Modifications of the in vitro metabolism of the hepatotoxic pyrrolizidine alkaloid, monocrotaline
Chesney, C.F.; Hsu, I.C.; Allen, J.R.
Research Communications in Chemical Pathology and Pharmacology 8(3): 567-570
1974
ISSN/ISBN: 0034-5164 PMID: 4853242 Document Number: 81896
Document emailed within 1 workday
Related Documents
Seawright, A.A.; Hrdlicka, J.; Wright, J.D.; Kerr, D.R.; Mattocks, A.R.; Jukes, R. 1991: The identification of hepatotoxic pyrrolizidine alkaloid exposure in horses by the demonstration of sulphur-bound pyrrolic metabolites on their hemoglobin Veterinary and Human Toxicology 33(3): 286-287Yan, C.C.; Huxtable, R.J. 1995: Effects of the pyrrolizidine alkaloid, retrorsine, on sulfur metabolism, in the liver Proceedings of the Western Pharmacology Society 38: 37-40
Pu, S.-b.; Xu, D.-r.; Zhang, M.; Zhou, H.-h.; Wang, Z.-t.; Yu, G.-d. 2004: Detection of hepatotoxic pyrrolizidine alkaloids in Ligularia Cass. with LC/MSn Yao Xue Xue Bao 39(10): 831-835
Winter, H.; Seawright, A.A.; Noltie, H.J.; Mattocks, A.R.; Jukes, R.; Wangdi, K.; Gurung, J.B. 1994: Pyrrolizidine alkaloid poisoning of yaks: identification of the plants involved Veterinary Record 134(6): 135-139
Leidinger, E.; Loupal, G.; Gutleb, R.; Miller, I.; Chizzola, R. 1992: Toxic effects in rabbits after immunization against the pyrrolizidine alkaloid retrorsine Deutsche Tierärztliche Wochenschrift 99(8): 332-335
Williams, D.E.; Reed, R.L.; Kedzierski, B.; Dannan, G.A.; Guengerich, F.P.; Buhler, D.R. 1989: Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver Drug Metabolism and Disposition: the Biological Fate of Chemicals 17(4): 387-392
Vetoshkina, T.V.; Dubskaia, T.I. 1993: The role of disruption of lipid metabolism in mechanisms of the hepatotoxic effects of cisplatin Voprosy Meditsinskoi Khimii 39(6): 23-26
Kajita, J.; Kuwabara, T.; Kobayashi, H.; Kobayashi, S. 2000: CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(9): 1121-1127
Büch, U.; Isenberg, E.; Büch, H.P. 1994: HPLC assay for atropine in serum and protein solutions after in vitro addition of the tropane alkaloid Methods and Findings in Experimental and Clinical Pharmacology 16(5): 361-365
Slesak, B.; Nowicky, J.W.; Harłozinska, A. 1992: In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes Drugs under Experimental and Clinical Research 18(Suppl): 17-21
Orbán, G.; Krámer, M.; Dworschák, E. 1970: Modifications of several indices of metabolism under the effect of a contraceptive agent administered orally Gynecologie Pratique 21(3): 223-228
Uluitu, M.; Chiş, R.; Bădescu, A. 1993: On some electrolytic and water metabolism modifications in rats susceptible to audiogenic convulsions Romanian Journal of Physiology 30(3-4): 139-150
Tabar, A.I.; Sanz, M.L.; Oehling, A. 1989: Regulator soluble factors of human IgE synthesis. III. "In vitro" modifications Allergologia et Immunopathologia 17(4): 183-188
Blasco, R.; Moreno, E.; Sanz, P.; Repetto, M. 1990: In vitro modifications of rat NTE and other esterases by chemicals which induce delayed neurotoxicity in vivo Veterinary and Human Toxicology 32(5): 435-439
Utsumi, T. 2003: Analysis of co- and post-translational modifications of proteins by in vitro and in vivo metabolic labeling Seikagaku. Journal of Japanese Biochemical Society 75(5): 373-378
Grosa, G.; Rocco, F.; Ceruti, M.; Dosio, F.; Brusa, P.; Biglino, G. 1993: In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane, and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study Farmaco 48(5): 677-690
Remy, J.; Martin, M.; Haag, J. 1984: Radiosensitivity of swine lymphocytes: in vitro modifications of the cell cycle and kinetics of the appearance of chromosomal aberrations Mutation Research 126(2): 169-175
El Marjou, M.; Montalescot, V.; Buzyn, A.; Geny, B. 2000: Modifications in phospholipase D activity and isoform expression occur upon maturation and differentiation in vivo and in vitro in human myeloid cells Leukemia 14(12): 2118-2127
Schimke, R.; Holán, V.; Sibl, O.; Hasek, M.; Ambrosius, H. 1981: Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man Neoplasma 28(3): 257-264
Kuperman, A.V.; Kalgutkar, A.S.; Marfat, A.; Chambers, R.J.; Liston, T.E. 2001: Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(11): 1403-1409